Mitral stenosis prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever. | Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever.<ref name="Nkomo2006">{{cite journal|last1=Nkomo|first1=V. T|title=Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa|journal=Heart|volume=93|issue=12|year=2006|pages=1510–1519|issn=1355-6037|doi=10.1136/hrt.2007.118810}}</ref> | ||
| Line 13: | Line 13: | ||
*[Measure1] | *[Measure1] | ||
*[Measure2] | *[Measure2] | ||
*[Measure3 | *[Measure3 | ||
==References== | ==References== | ||
Revision as of 14:11, 10 April 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever.
Primary Prevention
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever.[1]
Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3
References
- ↑ Nkomo, V. T (2006). "Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa". Heart. 93 (12): 1510–1519. doi:10.1136/hrt.2007.118810. ISSN 1355-6037.